Transforming cancer care

Jul 6, 2016
Transforming cancer care

What if you could transform the lives of those living with cancer with one bright idea? Well now you can with the Astellas Oncology C3 Prize, designed to inspire non-medicine innovations and bring them to life.

Five finalists will be invited to pitch their ideas to a panel of judges including Robert Herjavec, technology entrepreneur, passionate cancer caregiver and star of ABC’s Emmy Award-winning hit television show Shark Tank. A total of $100,000 in grants will be awarded as well as membership to healthcare technology incubator MATTER.

With the global cancer burden expected to grow to 22.2 million cancer cases by 2030, “there is a need for innovative tools and resources to help patients and those that care for them navigate the journey from diagnosis to hopefully survivorship,” said Mark Reisenauer, senior vice president, oncology sales and marketing, Astellas. “We want to hear fresh ideas and perspectives from people who want to make a difference in the lives of those living with cancer.”

The C3 Prize seeks entries in four key areas where the cancer community face the toughest obstacles to receiving or providing optimal care: navigating the health care system; adhering to complex medical care requirements; coordinating care and surviving life post-treatment.

Want to help change cancer care? If you have an idea you want to bring to light, entries will be accepted through 11:59 pm Central Time on August 8, 2016 at C3Prize.com.

You can also find further information here.

Transforming cancer care

Mark Reisenauer is senior vice president, oncology business unit. In this role, he is responsible for commercial activities supporting marketed products, Astellas’ co-promotion partners and commercial planning for early stage oncology development compounds. Reisenauer is a member of the Astellas US Management Committee.

Reisenauer joined Astellas in 2011 as vice president, sales and marketing, oncology, where he led commercial activities supporting oncology products.

Prior to joining Astellas, Reisenauer served as senior vice president and chief commercial officer of Micromet Inc. (now part of Amgen), where he led investor and public relations, new product planning, and commercial launch planning. Previously, Reisenauer held various sales and marketing leadership roles at Abbott, Pharmacia, Bristol-Myers Squibb and AstraZeneca.

Reisenauer earned a bachelor’s degree in political science from the University of Wisconsin.

Leave a Reply